Acute Coronary Syndrome
1,027
90
122
572
Key Insights
Highlights
Success Rate
91% trial completion (above average)
Published Results
103 trials with published results (10%)
Research Maturity
572 completed trials (56% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.5%
56 terminated out of 1027 trials
91.1%
+4.5% vs benchmark
23%
233 trials in Phase 3/4
18%
103 of 572 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 572 completed trials
Clinical Trials (1027)
Enhancing Rural Health Via Cardiovascular Telehealth for Rural Patients Implementation (E-VICTORS)
MERITnI - Mindray-hs-cTnI Assay: Analytical and Clinical Evaluation for the Diagnosis and RIsk AssessmenT of Myocardial InfarctIon.
Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions
Intrahospital Influenza Vaccination in Patients at High Cardiovascular Risk (VACC-UP)
PCSK 9 Inhibitor Added to High-Intensity Statin Therapy to Prevent Cardiovascular Events in Patients With ACS After PCI
Auricular Vagus Stimulation and STEMI
A Polypill for Acute Coronary Syndrome
Healthy Heart Habits-2
Effectiveness of a Resilience-Based Rehabilitation Program for Patients With Coronary Heart Disease
Switching From Ticagrelor to Prasugrel in Patients With Acute Coronary Syndrome
Revascularization Strategies in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome (NSTE-ACS) and Severe Coronary Artery Disease
Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System
Comparative Assessment of Inclisiran on Top of Standard of Care Versus Standard of Care Alone for LDL-C Evaluation in Acute Coronary Syndrome Patients in Saudi Arabia
A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome
Rehabilitation Exercise With MObile Technology and Education After Acute Coronary Syndrome
Potassium-Competitive Acid Blocker Versus pROton-Pump Inhibitor for GastroproTECTion Strategies In Patients at High Gastro-Intestinal Bleeding Risk Receiving Antithrombotic Therapy
Diagnostic Performance of Artificial Intelligence Algorithms in Prediction of Acute Coronary Syndrome Based on White Blood Cell Properties
Evaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary Syndromes
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI